CD8A and cancer: However, CD8+ cytotoxic T lymphocytes (CTLs) encounter dysfunction and exhaustion during cancer progression because cancer-associated fibroblasts (CAFs), macrophage type 2 (M2) cells, and regulatory T cells (Tregs) can act as immunological barriers against CD8 T cell-mediated antitumor immune responses (13).